Introduction

T
here is increasing pressure on health service funders around the world to accelerate the review process for new technologies in order to give patients early access to potentially transformative technologies. 1, 2 All proposals for early access require the support of ongoing safety and efficacy monitoring through observational data gathered after new technologies are available on the market. This can identify clinically important adverse effects that are less frequent in research than real world conditions, as well as assess the effectiveness of apparently efficacious technologies. 3 Studies based on routinely collected health service data could be an efficient way of assessing effectiveness, but methodological challenges include appropriate identification of comparator data and insufficiency of data for case mix adjustment. 4 There is therefore a place for well conducted observational data gathering through registers. Regulators have been concerned about the quality of evidence gathered in this way, however, leading to the development of quality standards to support the process. 5, 6 As part of its health technology assessment programs, the National Institute of Health and Care Excellence (NICE) has often recommended that registers collect data for technologies that require more evidence to allow and inform future decision-making. This has been particularly the case for the Interventional Procedures (IP) Programme, which provides guidance for UK health professionals on the safety and efficacy of new clinical procedures that involve making a cut through the skin, using instruments to enter the body (e.g. an endoscope) or equipment which uses energy sources (e.g. ultrasound) to diagnose or treat patients. These procedures are typically not well established, meaning that there is often a paucity of evidence on which to make recommendations. Since its establishment in 2003, IP guidance has frequently recommended the collection of further data in specific named registers, with the intention of enriching the evidence base for the technology in order to inform future reviews of the guidance.
The most recent operational manual for the IP programme specifies four standards that should be met by any recommended register (see Table 1 ). 7 Many of the registers recommended by NICE were assessed prospectively against the standards when guidance was written, but a retrospective audit of the registers has not been undertaken to date. We undertook a survey of registers recommended by the NICE IP Programme against these quality standards to (i) assess the fitness for purpose of recommended registers, and (ii) assess the quality of registers used in the NICE IP program since 2003.
Methods
Questionnaire development
We constructed a questionnaire based on the four IP quality standards as well as an additional question on data publication (see Supplementary File S1). This was piloted by the IP team as part of its ongoing work to develop procedure guidance.
Data collection
All IP guidance recommendations from 2003 to 2016 were reviewed to identify where recommendations for data collection through registers had been made and compile a list of corresponding registries (a registry is the system that supports one or more registers). Registries for registers recommended in multiple pieces of guidance were only asked to send one response. We made a maximum of four attempts to contact each registry: an initial email; a reminder email after 4 weeks if no response; a 'firm reminder' email sent from the Director of the IP team if no response after 8 weeks; and as a final measure emails sent to other contacts within the registry asking them to fill in the survey if no response after 10 weeks.
Quality scoring
Each register was scored independantly by the authors on seven quality standards: accessibility, responsiveness, data publication, data coverage, data validity, independent oversight and data protection. Each standard could score zero, one or two, giving a maximum of 14 points. The standards and scoring criteria are described in Table 2 . All registries were scored on accessibility and responsiveness, whereas only responding registries were scored on the other five standards. Objective evidence of data publication provided for the register was scored by one author. As data coverage, data validity, independent oversight and data protection were more subjective, three authors independently scored all survey responses for these four standards. A two-way mixed-effect averagemeasures absolute-agreement intraclass correlation coefficient was calculated for each of these standards. 8 For responding registries, the score for these standards was averaged and added to the scores for the other three standards to produce a total score for each register.
Results
In total, 28 registers have been recommended in IP guidance since 2003 (see Supplementary file S2). Four of these registers were excluded from the survey (see Figure 1 for flow of responses and reasons for exclusion). We obtained full responses from 17 of the 24 eligible registries, a response rate of 70.8%.
For responding registries, the mean total score was 8.5 (standard deviation 2.9, range [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Table 3 outlines the number of registries receiving scores of zero, one or two for each standard. The intraclass correlation coefficients for the multi-rated standards show a high inter-rater reliability for data coverage, but lower (although still significant) reliability for the other three standards.
With regard to accessibility, one in four registries did not have any contact details available on the internet. In contrast, a third had online data easily accessible for secondary analysis. Websites generally did not provide sufficient evidence to allow the standards to be assessed without contacting a registry representative. As for responsiveness, nearly a third of registries responded readily to our request for information. Nearly half, however, required follow-up with alternative contacts at the registry or did not respond at all. The large international registries (e.g. the International Registry of the Extracorporeal Life Support Organization (ELSO)) were particularly hard to communicate with because it took time to get through to a member of staff that could answer questions on quality.
For those registers where registry responses allowed quality to be assessed, scores broadly tended to be bimodal with either high or low scores across the range of quality standards. For example, nearly half of registers had not published any data at all compared to over 40% who had (often numerous) peer-reviewed publications. Similarly, over two fifths provided ample evidence that they were meeting data protection principles, while nearly the same proportion provided no or scant evidence. The majority of registers are managed by an independent steering group, but over half were not able to confirm that coverage of the data is routinely monitored and the data validated. The lowest agreement between raters was seen on the standard concerning the clinical relevancy of collected data, with registries rarely stating explicitly their process for making modifications to registers.
Discussion
We undertook a survey of all registers recommended in NICE IP guidance since 2003. We found the majority of registers inaccessible with relatively little information about the standard of data available from the register's website. Even when specifically asked for a response, a number of registries failed to provide any information that allowed an objective assessment against pre-defined quality standards. Amongst registers or whom information was received, standards relating to governance were more often met than those relating to data quality. This is the first study to our knowledge assessing the quality of registers recommended by health technology agencies specifically to support decision making. Overall, the quality of recommended registers was disappointing, with a split between large registries that scored highly across all standards and smaller registries that scored poorly. Registries are often willing to collaborate with regulatory and HTA bodies to help with providing relevant 'real world' data. 9 However, we have shown that only a limited number of registers recommended by NICE are mature enough to deliver evidence of sufficiently high quality to inform funding decisions. In order to ensure HTA bodies are only utilising registers that are fitfor-purpose, it is important to be able to distinguish between those registries capable of providing high-quality observational data and those that require more support to be able to do so.
Several authors have reviewed the important characteristics of a register that are required for it to deliver high quality data. 10, 11 Desirable qualities that have been described include strategic national collaborations amongst key stakeholders; an independent steering committee to lead and oversee the register; consensus meetings to agree register objectives, minimum dataset and data ownership; accessible data processing systems with training for users; data validation with specialist clinical support to question and feedback on data submitted. In order to evaluate whether a register should be recommended for observational data gathering, a standardised quality assessment tool that encompassed these characteristics would be useful. While some quality assessment tools already exist, including those developed by Parent, the Agency for Healthcare Research and Quality (AHRQ) and Eucomed, none of these have yet been become standard. [12] [13] [14] This work is useful in piloting methodology that can be developed in line with the needs of national initiatives to improve the validity and use of observational data in health technology assessment. We performed a comprehensive audit of recommended registers, supported by a rigorous process for scoring responses. We were constrained by the previously defined quality standards, which would have been more meaningful if a set of acceptable evidence were listed against which register submissions could be assessed. This was particularly a problem for the standard relating to data protection because respondents generally confirmed that all legal requirements relating to data protection and information governance are met but did not provide evidence. In conclusion, this audit has shown that not all registers recommended by NICE's IP Programme to date are capable of producing high quality evidence for post-market surveillance of new technologies. A standardised quality assessment tool is needed to evaluate registers before their recommendation for observational data gathering by decision-making bodies. This learning will be submitted to the EuneHTA Joint Action 3 Work Package 5 to inform the development of standards and tools to be used by the 78 partner organisations [http://www.eunethta.eu/news/coreworkpackages].
Supplementary data
Supplementary data are available at EURPUB online.
